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Supplemental	experimental	procedures	
Mouse	primary	neuronal	cultures	Mixed	 cortical/hippocampal	primary	neuronal	 cultures	were	prepared	 from	E16	 ICR	(CD-1®)	 outbred	 mice	 (Harlan	 Laboratories,	 Horst,	 Netherlands).	 Cortices	 with	adjacent	hippocampi	were	dissected	in	ice-cold	HBSS,	incubated	in	7ml	TrypLe	Express	for	10min	at	37°C	and	triturated	in	Dulbecco’s	modified	Eagle’s	medium	(DMEM)	(1g/l	glucose)	 containing	 5%	 FCS	 (all	 from	 Life-Technologies)	 through	 repeated	 pipetting	with	a	5ml	serological	pipette	and	passed	through	a	70µM	cell	strainer.	Neurons	were	cultured	on	poly-D-lysine	(Sigma	Aldrich,	St.	Gallen,	Switzerland)	coated	96-well	plates.	Cells	 were	 cultured	 in	 DMEM	 containing	 5%	 FCS	 for	 the	 initial	 12h,	 thereafter	 the	medium	was	changed	to	Neurobasal	medium	supplemented	with	B27	(1:50)	and	1mM	GlutaMax	(all	from	Life	Technologies,	Zug,	Switzerland).		
Human	iPSC-derived	neurons	Human	induced	pluripotent	stem	cells	(iPSC)	from	two	healthy	male	donors	(33-years	and	34-years	old)	were	maintained	in	DMEM/F12,	2	mM	L-glutamine,	1.6	g/l	glucose,	0.1	 mg/ml	 penicillin/streptomycin,	 N2	 supplement,	 B27	 (1:1000)	 (all	 from	 Life-Technologies),	 and	 10	 ng/ml	 fibroblast	 growth	 factor	 2	 and	 10	 ng/ml	 epidermal	growth	 factor	 (both	 from	Cell-Guidance-Systems)	on	poly-L-ornithine/laminin	coated	plates	 (both	 from	 Sigma-Aldrich).	 Neurons	 were	 differentiated	 by	 growth	 factor	withdrawal	 for	 4	 weeks	 in	 differentiation	 medium	 (MACS	 Neuro	 Medium	supplemented	 with	 MACS	 NeuroBrew-21	 (1:50)	 (both	 from	 Miltenyi-Biotec))	 and	DMEM/	 F12	 supplemented	 with	 N2	 (mixed	 at	 1:1	 ratio)	 that	 was	 exchanged	 every	other	day.			
HEK-BACE1	cells	HEK	 cells	 stably	 expressing	 BACE1	 (kind	 gift	 from	 Prof.	 D.	 Selkoe)	were	 cultured	 in	high-glucose	 DMEM	 (Life	 Technologies)	 containing	 10%	 FCS.	 All	 experiments	 were	performed	between	passage	5	and	15.		
siRNA	transfection		4DIV	 primary	 neurons	 were	 transfected	 with	 100nM	 of	 siRNA	 (stealth	 siRNA,	 Life	Technologies,	Zug,	Switzerland)	using	Lipofectamine	RNAiMax	(Life	Technologies,	Zug,	Switzerland)	as	transfection	reagent.	A	pool	of	four	different	siRNAs	was	used	for	each	gene.	 A	 pool	 of	 three	 different	 non-targeting	 siRNAs	 served	 as	 negative	 control.	 For	each	well	of	a	96well	plate,	0.45µl	of	RNAiMax	were	mixed	with	siRNA	and	Neurobasal	in	 a	 final	 volume	 of	 20µl	 and	 incubated	 for	 20min	 at	 room	 temperature.	 Each	transfection	 mix	 was	 filled	 up	 to	 100µl	 with	 culture	 medium	 (Neurobasal	supplemented	with	B27	and	GlutaMax).	The	medium	on	the	primary	neuronal	cultures	was	 replaced	 with	 the	 transfection	 mix	 and	 incubated	 for	 6h	 in	 the	 cell	 culture	incubator,	after	which	cells	were	again	placed	in	fresh	culture	medium.			siRNA	sequences:		negative	controls	 	 Catalog	number	(Life	Technologies)		 medGC	duplex	#1	 12935-111			 medGC	duplex	#2	 12935-112			 medGC	duplex	#3	 12935-113		 	 	target	gene	 	 	APP	 Sense	sequence	1	 GCGGAUGGAUGUUUGUGAGACCCAU			 Sense	sequence	2	 UCAGGAUUUGAAGUCCGCCAUCAAA	
		 Sense	sequence	3	 GACCAGGUUCUGGGCUGACAAACAU			 Sense	sequence	4	 CACACACCCACAUCGUGAUUCCUUA		 	 	BACE1	 Sense	sequence	1	 GAGCCCUUCUUUGACUCCCUGGUGA			 Sense	sequence	2	 GAGGGAGCAUGAUCAUUGGUGGUAU			 Sense	sequence	3	 CAUCCGGCGGGAGUGGUAUUAUGAA			 Sense	sequence	4	 GGCAGUGCAAGAGUCACAUUGUUAU		 	 	PSEN1	 Sense	sequence	1	 ACUCUCUUUCCAGCUCUUAUCUAUU			 Sense	sequence	2	 GCACCUUUGUCCUACUUCCAGAAUG			 Sense	sequence	3	 UCGACUGCAGCAGGCGUAUCUCAUU			 Sense	sequence	4	 ACCAUCAAAUCAGUCAGCUUCUAUA		 	 	PSEN2	 Sense	sequence	1	 AGUUCAUCCAUGGCUGGCUGAUCAU			 Sense	sequence	2	 CCACUAUCAAGUCUGUGCGUUUCUA			 Sense	sequence	3	 GAGAUGGAAGAAGACUCCUACGACA			 Sense	sequence	4	 CCCAGGAGAGAAAUGAGCCCAUAUU		 	 	ADAM10	 Sense	sequence	1	 GCAUCUGAUCCCAAGCCCAACUUUA			 Sense	sequence	2	 CCUGAUCAUGUUAAUGGCUGGAUUU			 Sense	sequence	3	 CCUGCCAUUUCACUCUGUCAUUUAU			 Sense	sequence	4	 ACGCACAACUCUGGCUGAAAGAAAU		 	 	APH1C	 Sense	sequence	1	 CCCAUCUAUGCAGUCACCGUUUCCA		 Sense	sequence	2	 GACUCACCCUAUUACUUCCUGACUU		 Sense	sequence	3	 AAGAAGGCAGAUGAGGGCUUAGCAU		 Sense	sequence	4	 CACCUUCUGACAUCGGGACUGACAU		 	 	APH1B	 Sense	sequence	1	 GACCCUUUGCGAGUCAUCUUCCUCA		 Sense	sequence	2	 GGUGUCUCUCCUGCUGUCAUCCGUU		 Sense	sequence	3	 GCGCUCGCUCUUUAUGUCUUCACCA		 Sense	sequence	4	 CAGUACAGAAUUACCUGCUCAUCUU		 	 	APH1C	 Sense	sequence	1	 GGUUCCUAGUGAGAGUCAUUACUAA		 Sense	sequence	2	 CAACAGAGAUGAAUCAGUACAGAAU	
	 Sense	sequence	3	 GAGCUGUUCAGGCUCGCAUAUUAUA		 Sense	sequence	4	 GCGUUGCUCUCUGUCUGUAUCCAAG		
Plasmid	transfection		HEK-BACE1	 cells	were	 seeded	 at	~30%	 confluency	 in	 DMEM	 containing	 5%	 FCS	 on	PDL-coated	48well	plates	at	~3h	before	 transfection.	For	each	well	of	 a	48well	plate	50ng	 plasmid	 DNA	 and	 0.3µl	 of	 Lipofectamine2000	 transfection	 reagent	 (Life	Technologies,	 Zug,	 Switzerland)	 were	 mixed	 in	 OPTI-MEM	 (Life	 Technologies,	 Zug,	Switzerland)	in	a	final	volume	of	10µl	and	incubated	for	20min	at	room	temperature.	Each	 transfection	mix	was	 filled	up	 to	30µl	with	DMEM	containing	5%	FCS	and	 then	added	to	the	medium	(250µl)	on	the	cells.	~16h	after	addition	of	the	transfection	mix,	280µl	 of	DMEM	containing	15%	FCS	were	 added	 to	 each	well	with	 transfected	 cells.	APP695wildtype	 plasmid	 was	 kindly	 provided	 by	 Dr.	 Uwe	 Konietzko.	 Mutations	 were	introduced	 with	 the	 Quik-Change	 Lightning	 Site	 Directed	 Mutagenesis	 Kit	 (Agilent,	Basel,	Switzerland)	following	manufacturer’s	instructions.	
Alamar	Blue	assay	Alamar	blue	TM	assay	reagent	 (AbD	Serotec	Ltd,	Bio-Rad,	Cressier,	Switzerland)	was	added	 at	 a	 final	 concentration	 of	 10%	 to	 the	 cell	 culture	 medium	 for	 3h	 before	termination	 of	 the	 medium	 collection	 period.	 544EXnm/590EMnm	 fluorescence	measurements	 were	 taken	 with	 a	 Spectra	 MAX-GEMINI-XS	 spectrofluorometer	(Molecular-Devices,	Sunnyvale,	CA,	USA).	
BCA	assay	Human	 iPSC	 derived	 neurons	 were	 lysed	 in	 TBS	 containing	 0.1%	 SDS,	 1%	 NP40	supplemented	 with	 protease	 inhibitor	 cocktail	 (Complete™	 Mini,	 EDTA-free;	 Sigma	
Aldrich,	 Buchs,	 Switzerland).	 Lysates	 were	 cleared	 from	 genomic	 DNA	 by	 5min	centrifugation	at	2000	x	g	and	protein	concentrations	were	determined	by	Pierce	BCA	assay		(Thermo	Scientific,	Waltham,	MA	USA)	following	manufacturer’s	instructions.			
RNA	isolation	For	RNA	extraction	adherent	neurons	were	washed	with	PBS	and	lysed	in	TRI-Reagent	(Sigma-Aldrich,	 Buchs,	 Switzerland).	 Technical	 quadruplicates	 of	 each	 experimental	condition	 were	 pooled	 and	 isolation	 of	 RNA	 was	 performed	 according	 to	manufacturer’s	 instructions.	 All	 RNA	 samples	 were	 subjected	 to	 DNaseI	 treatment	(Fermentas;	Life	Technologies,	Zug,	Switzerland).		
cDNA	synthesis	500ng	of	total	RNA	were	reverse-transcribed	using	the	iScript	cDNA-synthesis-kit	(Bio-Rad,	Cressier,	Switzerland)	following	the	manufacturer’s	protocol.		
Real-time	PCR	Real-time	 PCR	 for	 relative	 quantification	 of	 cDNA	 levels	 was	 performed	 with	 the	7900HT	Real-Time	PCR	System	(Life-Technologies,	Zug,	Switzerland),	using	the	 iTaq-SybrGreen	 Supermix	 with	 ROX	 (Bio-Rad,	 Cressier,	 Switzerland).	 Relative	 gene	expression	 levels	 were	 calculated	 with	 the	 ∆∆CT-method	 using	 GAPDH	 for	normalization.		Primer	sequences:	Gene		 		 	GAPDH	 Forward	primer	 5'	AGGUCGGUGUGAACGGAUU	3'			 Reverse	primer	 5'	GGGUCGUUGAUGGCAACA	3'	APP	 Forward	primer	 5'	ACCGUUGCCUAGUUGGUGAGU	3'			 Reverse	primer	 5'	CGGUGUGCCAGUGAAGAUG	3'	BACE1	 Forward	primer	 5'	CGGCAGACAUGGAAGACUGU	3'			 Reverse	primer	 5'	AGGCAGAGUGGCAACAUGAA	3'	
PSEN1	 Forward	primer	 5'	CGUGGCCACCAUCAAAUC	3'			 Reverse	primer	 5'	GAUCGAGUGCAGGGCUCUU	3'	PSEN2	 Forward	primer	 5'	GAUGGAAGAAGACUCCUACGACAG	3'			 Reverse	primer	 5'	CUUCACGCCCCUUUCCUC	3'	ADAM10	 Forward	primer	 5'	GCUGGGAGGUCAGUAUGGAA	3'			 Reverse	primer	 5'	UCAUGUGAGACUGCUCGUUUG	3'	APH1A	 Forward	primer	 5'	AAGCUCCUUAAGAAGGCAGAUGA	3'		 Reverse	primer	 5'	GAUACCGAAGGACAGACCAGAA	3'	APH1B	 Forward	primer	 5'	AGUCAUUACUGACAACAGAGAUGGAC	3'		 Reverse	primer	 5'	GAGGGUGCUGUCUCCUCA	3'	APH1C	 Forward	primer	 5'	UGAGAGUCAUUACUAACAACAGAGAUGAAU	3'		 Reverse	primer	 5'	CGCAUCGAGGGUGCUAUG	3'		
SDS-PAGE	and	Western	blot	Inhibitor	 treated	 mouse	 primary	 neurons	 were	 lysed	 in	 PBS,	 1%	 NP40,	 0.1	 %	 SDS	supplemented	 with	 protease	 inhibitor	 cocktail	 (Complete™	 Mini,	 EDTA-free;	 Sigma	Aldrich,	Buchs,	 Switzerland).	Protein	 from	siRNA	 transfected	neurons	was	 recovered	from	 the	 organic/phenol	 phase	 that	 was	 obtained	 during	 RNA	 isolation	 with	 TRI-Reagent	(Sigma-Aldrich,	Buchs,	Switzerland)	following	the	manufacturer’s	protocol	for	protein	 precipitation	 with	 acetone.	 The	 obtained	 protein	 pellet	 was	 resuspended	 in	9.5M	 Urea	 (pH9.0),	 2%	 CHAPS.	 HEK-BACE1	 cells	 were	 lysed	 in	 PBS,	 1%	 NP40	supplemented	 with	 protease	 inhibitor	 cocktail	 (Complete™	 Mini,	 EDTA-free;	 Sigma	Aldrich,	Buchs,	Switzerland).	HEK-cell	 lysates	were	treated	with	λ-phosphatase	(NEB,	Hitchin,	 UK).	 For	 analysis	 of	 APP	 CTFs	 upon	 inhibitor	 treatment,	 proteins	 were	separated	 by	 SDS-PAGE	 using	 10-20%	 Tris-Tricine	 gels	 (Life	 Technologies,	 Zug,	Switzerland).	For	all	other	conditions,	proteins	were	separated	on	4-20%	Tris-Glycine	gels	 (Bio-Rad,	 Cressier,	 Switzerland).	 	 Proteins	were	blotted	on	0.2µm	Nitrocellulose	membranes	 (Bio-Rad,	 Cressier,	 Switzerland).	 Unspecific	 binding	 was	 blocked	 by	preincubation	of	membranes	with	TBS-Tween(0.05%)	containing	5%	w/v	nonfat	milk	
powder.	 Incubation	 with	 primary	 antibodies	 was	 performed	 over	 night	 at	 4°C,	incubation	with	 secondary	 antibodies	 for	1h	 at	 room	 temperature.	 Infrared	 signal	 at	700nm	 and	 800nm	 were	 acquired	 with	 an	 Odyssey	 CLx	 Imaging	 System	 (Li-COR	Biosciences,	Bad	Homburg,	Germany).			Primary	antibodies	 Provider	and	product	number	 Antibody	dilution	used	mouse	 anti-Aβ	(rat/mouse)	(M3.2	clone)	 Covance	#	SIG39155	 1:500	rabbit	anti-APP		(C-terminus)	(Y188)	 Abcam	#	ab	32136	 1:1000	rabbit	anti-APP		(C-terminus)	(CT15)	 Sigma	Aldrich	#	A8717	 1:1000	rabbit	anti-BACE1	 Abcam	#	ab108394	 1:1000	rabbit	anti-PSEN1	 Abcam	#	ab76803	 1:1000	rabbit	anti-PSEN2	 Abcam		#	51249	 1:2000	rabbit	anti-ADAM10	 Calbiochem		#732-748	 1:1000	rabbit	anti-APH1A		 Kindly	provided	by	Bart	De	Strooper	B80.3	clone	 1:1000	rabbit	anti-APH1B/C		 Kindly	provided	by	Bart	De	Strooper	B78.2	clone	 1:250	mouse	anti-cMyc	(9E10)	 Santa	Cruz	#	sc-40	 1:1000	mouse	anti-β-Actin	 Abcam	#ab6276	 1:10000	mouse	anti-GAPDH	 Life	Technologies	#AM4300	 1:5000			Secondary	antibodies	 Provider	and	product	number	 Antibody	dilution	used	donkey	anti-mouse		IRDye	800CW		 Li-COR	Biosciences	#	926-32212	 1:5000	donkey	anti-mouse		IRDye	680RD		 Li-COR	Biosciences	#	926-68072	 1:5000	donkey	anti-rabbit	IRDye	800CW	 Li-COR	Biosciences	#	926-32213	 1:5000		
SULFO-Tag	conjugation	of	antibody	Anti	 mouse/rat-Aβ	 (M3.2	 mAb)	 antibody	 (Covance	 SIG-39155)	 was	 conjugated	 to	SULFO-Tag	using	SULFO-TAG	NHS-Ester	reagent	(Meso-Scale-Discovery)	at	1:20	ratio	following	 the	 manufacturer’s	 protocol.	 The	 tagged	 antibody	 was	 separated	 from	unconjugated	SULFO-TAG	NHS-Ester	reagent	using	a	ZEBA	Spin	Column	0.5ml	40kDa	MW	cut-off	(Thermo	Scientific,	Waltham,	MA	USA)	
Electrochemiluminescence	assay		24h	 conditioned	medium	 of	 8DIV	mouse	 primary	 neurons	 or	HEK-BACE1	 cells	 (72h	post-transfection)	 or	 20h	 conditioned	medium	 of	 human	 iPSC	 derived	 neurons	 was	used	 for	 analysis.	Mouse	 or	 human	 [Aβ/Aβ’+p3]40	 and	 [Aβ/Aβ’+p3]40	were	 analyzed	with	 the	 Aβ-Panel-1	 Kit	 (4G8)	 (Meso-Scale-Discovery).	 Murine	 Aβ40	 and	 Aβ42	 were	analyzed	 with	 the	 Aβ-Panel-1	 Kit	 assay	 plate	 (Meso-Scale-Discovery)	 together	 with	SULFO-TAG	anti	mouse/rat-Aβ	(M3.2	mAb)	antibody.	sAPPα	and	sAPPβ	were	analyzed	with	 the	 sAPPα/sAPPβ	 multiplex	 assay	 (Meso-Scale-Discovery).	 Conditioned	 media	from	pimary	neuronal	 cultures	were	 analyzed	undiluted.	Conditioned	media	of	HEK-BACE1	 cells	 were	 diluted	 1:5	 for	 sAPPα/sAPPβ	 measurements	 in	 order	 to	 reach	analyte	concentrations	within	the	linear	detection	range.	Undiluted	conditioned	media	of	HEK-BACE1	cells	was	used	for	Aβ	multiplex	assays.	Samples	from	γ-secretase	in	vitro	cleavage	 assay	 were	 diluted	 1:15	 to	 1:30	 in	 order	 to	 reach	 analyte	 concentrations	within	the	linear	detection	range.	Sample	incubation	was	performed	either	over	night	at	4°C	 (for	Aβ	 assays)	or	 for	2h	at	 room	 temperature	 (for	 sAPPα/sAPPβ	 assay).	4G8	mAb,	6E10	mAb	and	anti-APP	detection	antibodies	were	used	at	1:50	dilutions,	M3.2	mAb	at	a	concentration	of	1µg/ml.	Measurements	were	taken	on	a	Sector-Imager-6000	(Meso-Scale-Discovery).	 For	 primary	 neurons,	 ECL	 values	 were	 normalized	 to	 the	
corresponding	Alamar-Blue	assay	values.	For	human	iPSC	derived	neurons,	ECL	values	were	normalized	 to	BCA	assay	measurements.	Human	Aβ40	 and	Aβ42	 and	sAPPα	 and	sAPPβ	 standards	 were	 supplied	 with	 the	 respective	 kits.	 Mouse	 Aβ40	 and	 Aβ42	standards	were	obtained	from	rPeptide	(Bogart,	GA,	USA).	
γ	-Secretase	activity	assay	γ-Secretase	assays	using	recombinant	human	APP	C99-His,	C89-His	and	C83-His	were	performed	as	previously	reported	(Cacquevel	et	al.,	2008;	Dimitrov	et	al.,	2013;	Wu	et	al.,	 2010).	 γ-Secretase	 purified	 from	 S20	 CHO	 cells	was	 solubilized	 in	 0.2%	 (wt/vol)	CHAPSO,	 50	mM	 HEPES	 (pH	 7.0),	 150	mM	 NaCl,	 5	 mM	MgCl2	 and	 5	 mM	 CaCl2	 and	incubated	at	37°C	for	4	h	with	1	µM	substrate,	0.1%	(wt/vol)	phosphatidylcholine	and	0.025%	 (wt/vol)	 phosphatidylethanolamine.	 The	 generated	 product	 AICD-His	 was	analyzed	 by	 Western	 Blot	 and	 immunoprecipitation-mass	 spectrometry	 (IP-MS)	 as	previously	described	(Dimitrov	et	al.,	2013).	For	details	see	supplementary	material.	
Immunoprecipitation-mass	spectrometry	(IP-MS)	analysis	of	AICD-His	AICDs	generated	in	γ-secretase	in	vitro	assays	with	purified	APP	C99-His	,	C89-His	and	C83-His	 substrates	 were	 analyzed	 as	 previously	 described	 (Dimitrov	 et	 al.,	 2013).	Briefly,	 Triton	 X-100	 was	 added	 to	 a	 final	 concentration	 of	 1%	 (vol/vol)	 after	 the	enzymatic	 reaction	 and	 incubated	 for	 20	 min	 at	 55°C	 prior	 to	 overnight	immunoprecipitation	at	4°C	with	rabbit	anti-APP	C-terminus	antibody	(CT15)	(Sigma-Aldrich	 GmbH,	 Buchs,	 Switzerland)	 and	 protein	 A	 coupled	 to	 agarose	 resin	 (Roche	Applied	 Science,	 Penzberg,	 Germany).	 AICD-His	 was	 eluted	 with	 1:20:20	 (v:v:v)	 1%	(vol/vol)	 trifluoroacetic	 acid:acetonitrile:H2O,	 equally	 mixed	 with	 saturated	 sinapic	acid	and	analysed	by	MALDI-TOF	mass	spectrometry	 in	 linear	mode	on	an	ABI	4800	MALDI-TOF/TOF	mass	spectrometer	(Applied	Biosystems,	Carlsbad,	California,	USA).		
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Suppl. Fig.1: ECL multiplex assay standard curves 
The range of measured analyte concentrations for the control conditions of the cell-based experiments is 
indicated by the dashed box on each standard curve. 
(A) Standard curves for human/mouse [Aβ/Aβ’ + p3] assays (4G8 detection antibody) with mouse Aβ40 and Aβ42 
standards (upper panels) and human Aβ40 and Aβ42 standards (lower panels).  
(B) Standard curves for mouse Aβ assay (M3.2 detection antibody) with mouse Aβ40 and Aβ42 standards.  
(C) Standard curves for human Aβ assay (6E10 detection antibody) with human Aβ40 and Aβ42 standards.  
(D) Standard curves for human sAPPα/β assay with human sAPPα and sAPPβ standards.  
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Suppl. Fig.2: Low APH1B and APH1C expression in mouse primary neurons and mouse brain  
(A) APH1B/C protein levels in lysates of siRNA-transfected mouse primary neurons were below detection limit by Western Blot.  
The rabbit anti-APH1B/C antibody (B78.2 clone) that was kindly provided by Bart de Strooper is a validated antibody that had 
been able to detect APH1B/C in different murine tissues and in a mouse embryonic fibroblast cell line (Hebert et al.. 2004; 
Serneels et al., 2005) 
(B) The APH1B, APH1C and APH1A mRNA expression table for different tissues of CD1 mice (generated with the EMBL-EBI 
online gene expression atlas; http://www.ebi.ac.uk/gxa) shows very low mRNA expression of both APH1B and APH1C in the 
brain compared to APH1A.  
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